BlackRock, Inc. - Jun 30, 2025 SCHEDULE 13G Report for Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Amylyx Pharmaceuticals, Inc. Common Stock
Symbol: AMLX
Shares outstanding: 89.4M shares
Disclosed Ownership: 4.92M shares
Ownership: 5.5%
Form type: SCHEDULE 13G
Date filed: 7/17/2025, 07:44 PM
Date of event: Jun 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.5%	4.92M	4.83M	0	Spencer Fleming	Managing Director